New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations in diagnosis and treatment.

Treatment for Parkinson's focuses on managing its many symptoms, as there is no cure. But a new stem cell therapy developed at Memorial Sloan Kettering Cancer Center for advanced Parkinson's is ...

N E W   Y O R K, June 12 -- Leading neurologists say a change in drug treatment for Parkinson's patients could reduce uncontrollable body tremors for many in the early stages of the disease ...

New Parkinson’s treatment developed at Stanford could help millions Adaptive Deep Brain Stimulation isn’t a cure — but it’s a total game changer ...

Scientists have demonstrated an exciting proof of concept for treating Parkinson's in mice, whereby inhibiting a single gene is a one-time treatment eradicated the disease entirely, and kept it at ...